State of Healthcare Claim Denials 2026: Rates, Sources, and Measurement

TL;DR

A healthcare claim denial rate is only comparable when its population, denominator, reporting period, and definition match. This guide explains how to measure initial denials, interpret payer data, estimate your own rework costs, and evaluate prevention workflows. It does not establish a verified national 2026 denial rate or rank payers by an unsupported industry average.

Evidence status: This is an operational measurement guide, not an original QuickIntell benchmark study. Earlier national estimates and payer-level comparisons have been withdrawn because this page did not provide a reproducible dataset or adequate source attribution for them. That does not establish that every prior figure was false; it means those figures should not be relied on as substantiated findings. Full-year 2026 results are not available from a year that is still in progress.

What does a healthcare claim denial rate measure?

Before comparing performance, decide which event your report counts. A claim rejected before adjudication, a prior authorization request denied before treatment, an initially denied claim, and a final write-off are different events. Combining them can create a higher-looking rate without showing where the operational problem actually occurs.

For an internal first-adjudication cohort, use:

Initial denial rate = unique claims denied at first adjudication ÷ unique claims with a first adjudication in the same cohort × 100.

Document how you classify partially denied claims, reversals, replacements, and claims with multiple lines. If your existing reporting standard uses submitted claims rather than adjudicated claims as the denominator, keep that definition explicit and account for pending claims. Do not silently compare the two definitions.

Measure	What to count	Important limitation
Initial denial rate	Unique claims with an initial denial relative to the defined claim cohort	Claim-level and line-level rates are not interchangeable
Denied-dollar exposure	Denied amount for the cohort using a documented dollar basis	Billed charges are not the same as expected reimbursement
Appeal overturn rate	Appeals resolved favorably divided by resolved appeals in the defined cohort	Excludes unappealed denials and unresolved appeals
Final write-off rate	Amount ultimately written off relative to the chosen revenue basis	Requires enough follow-up time to observe final outcomes
Rework effort	Staff time and direct costs attributable to denial handling	Do not count the same labor in several cost categories

Use a written definition sheet so finance, billing, and analytics teams can reproduce the result. Keep the definition stable across comparison periods; annotate any system migration or classification change.

Primary sources: what public data can and cannot tell you

CMS Exchange claims and appeals data

CMS publishes a Transparency in Coverage public-use file containing issuer- and plan-level claims and appeals information. Start with the CMS Exchange Public Use Files directory, then read the relevant year's documentation and disclaimer before calculating a rate.

This is a defined Exchange dataset, not a sample of every US medical claim. Check the service year, market, claim type, and whether a field is issuer-level or plan-level. A national all-payer estimate cannot be inferred simply by combining selected rows or labeling the file's publication year as the claim year.

Prior authorization reporting is not claim-denial reporting

Under CMS-0057-F, impacted payers must publish specified prior authorization metrics, with initial reporting due March 31, 2026. The rule also requires specific denial reasons beginning in 2026. These provisions concern the impacted payer categories and non-drug items and services; they should not be presented as a universal rule for every payer or every authorization. CMS final-rule fact sheet

CMS clarifies that the first report covers calendar year 2025. A report published in 2026 is therefore not necessarily evidence about 2026 authorization outcomes. Keep authorization request counts separate from adjudicated claim counts. CMS prior authorization reporting FAQ

Adjustment codes describe reasons, not national prevalence

X12 maintains the Claim Adjustment Reason Code list. Use that authoritative reference with the applicable remark codes and payer response when interpreting an adjustment. A code list defines reasons; it does not establish which reasons account for the most denied claims nationally.

Our denial-code lookup is a starting point for operational research. Confirm the applicable payer policy and claim context before deciding whether an adjustment represents a denial, contractual adjustment, patient responsibility, or another outcome. Do not classify every adjusted dollar as denied revenue.

How to compare denial rates by payer

Build comparisons within comparable populations rather than ranking entire payer brands. A single payer name can span different products, legal entities, states, networks, and administrative arrangements.

For each payer cohort, record:

• Payer and plan/product identifier, with the source used to map them.
• Line of business, geography, network status, and service setting.
• Service date, first-adjudication date, and observation cutoff.
• Claim count, denied claim count, pending count, and dollar basis.
• Specialty or service category and the reason-code grouping rules.
• Source-system coverage, exclusions, and missing-data limitations.

Compare like-for-like cohorts across periods. When a payer's overall rate moves, check whether its specialty mix, plan mix, or processing lag changed before attributing the difference to a policy or operational intervention. Small cohorts should not support confident rankings; show their size and uncertainty instead.

The payer directory can help locate payer-specific operational references, while payer policies provide reviewed document context where available. Those reference pages are not payer performance ratings.

Build a denial-reason worklist from your own data

The following categories are a suggested internal triage structure, not a measured national distribution. A claim may have multiple adjustments, so define one primary cause for aggregate reporting while retaining all source codes for investigation.

Operational category	Evidence to examine	Possible next step
Eligibility and coverage	Eligibility response, member identifiers, coverage dates, coordination of benefits	Confirm the relevant coverage and correct a supported data error
Authorization	Authorization record, service details, validity period, payer decision	Reconcile the claim to the authorization and applicable policy
Documentation or medical necessity	Denial notice, submitted records, coverage criteria	Route for qualified clinical review rather than invent supporting documentation
Coding and claim data	Submitted codes, modifiers, demographics, payer edits	Review the underlying record and correct supported errors
Duplicate or replacement handling	Original claim, subsequent submissions, adjudication history	Reconcile claim lineage before submitting again
Filing or appeal deadlines	Submission receipts, notices, contract and applicable appeal rules	Verify the actual deadline and any supported exception

Do not treat an initial classification as the final root cause. Record what investigation established, who owns the corrective action, and whether the action prevents recurrence. The denial-management guide explains the broader follow-up workflow.

Estimate denial costs without an unsupported industry average

Measure work in your own operation before using a cost-per-denial assumption for a business case. Track investigation, correction, clinician input, appeal preparation, follow-up, and quality review separately.

Direct rework cost = attributable staff hours × fully loaded hourly cost + attributable transaction and delivery costs.

Then divide by the number of distinct denial cases worked if you need an average per case. Include abandoned and unsuccessful cases when they consumed effort. Explain whether recurring software charges and management time are allocated into the calculation.

Report the following separately rather than adding them without reconciliation:

• Operating expense: the labor and direct costs of working denials.
• Delayed cash: collectible amounts awaiting resolution, with any financing assumptions stated.
• Recovered cash: actual payments received after correction or appeal.
• Final loss: supported write-offs after the resolution process is complete.

An unpaid balance is not automatically a permanent loss. Likewise, an overturned denial does not by itself establish that cash has been collected. Link resolution outcomes to remittance and payment-posting records. Our ROI calculator can support scenario planning; its inputs are assumptions, not national denial-cost evidence.

Evaluate denial prevention and AI on a defined cohort

Do not infer that a tool caused improvement simply because organizations using it have different denial rates. Payer mix, staffing, baseline workflow, and selection of easier claims can affect the comparison.

Before a pilot, document the workflow being changed, the eligible cohort, baseline period, comparison method, observation period, and reviewer responsibilities. Measure both intended benefits and failure modes:

1. Track first-adjudication denials with the same denominator before and after the change.
2. Track missing or incorrect suggestions, manual overrides, and cases held for additional evidence.
3. Measure time per worked case, including review and correction of automation output.
4. Follow appeals through resolution and payment rather than reporting drafted appeals as recovered revenue.
5. Check for changes in claim volume, service mix, payer mix, pending inventory, and staffing.
6. Retain qualified human review for clinical documentation, coding decisions, and appeals requiring judgment.

AI may assist with detecting missing information, routing work, and assembling evidence. The size of any improvement must be established from the evaluated workflow; this guide makes no universal accuracy, recovery, or denial-reduction promise. For evaluation criteria, see denial prevention software.

A practical denial-review cadence

Use operational reviews to turn reporting into specific corrections, not just a dashboard of rates.

• Work queue: identify approaching deadlines, missing evidence, and unassigned cases.
• Root-cause review: inspect recurring denial categories and confirm ownership of upstream fixes.
• Cohort review: compare mature periods using unchanged definitions and document incomplete outcomes.
• Change log: record payer-policy changes, system releases, staff training, and metric-definition changes that could affect interpretation.

Set targets from your own baseline and capacity. A generic threshold is not evidence that a practice is performing well or poorly, and a falling overall rate can conceal a growing problem in a particular service line.

What an original benchmark would need

A publishable benchmark requires an identified dataset, collection period, inclusion and exclusion rules, payer and specialty coverage, claim/line definitions, deduplication logic, sample sizes, missing-data treatment, privacy safeguards, and reproducible calculations. It also needs appropriate approval for publication and a clear explanation of who the results represent.

QuickIntell has not published that original dataset with this guide. Customer names, proprietary payer rates, and comparative AI outcomes should not be inferred from it. Any future study must be evaluated on its own disclosed methodology rather than inherit credibility from this URL.

Frequently Asked Questions

What is the average healthcare claim denial rate in 2026?

This guide does not establish a verified all-payer national rate for 2026. Use a source with a clearly defined population, observation year, and denominator, and do not confuse a report's publication year with its data year. For internal improvement, a consistently defined baseline is more actionable than an unsupported national estimate.

Which payer has the highest denial rate?

There is no substantiated all-payer ranking on this page. Compare matched plan, service, geography, and time cohorts with sufficient claim volume. Payer-brand totals alone can hide meaningful differences in the business being compared.

What are the most common denial codes?

Rank the codes in your own remittance data after classifying adjustments correctly. The X12 code list supplies definitions, not national frequency statistics. Retain accompanying remark codes and payer context when investigating a case.

How much does a denial cost to rework?

Calculate attributable staff time and direct costs from worked cases in your organization. State whether the result includes unsuccessful work, software allocation, and management overhead. Keep rework costs, delayed cash, and final write-offs separate to avoid double counting.

Can AI reduce denial rates?

AI can support prevention, work routing, and evidence preparation, but results depend on the workflow, data quality, review controls, and cohort. Evaluate it against a documented baseline and measure errors, labor, final dispositions, and collected payments as well as the initial denial rate.

---

For a discussion of your denial workflow, contact QuickIntell. Do not submit patient information through the public contact form. Any evaluation should define evidence access, privacy controls, measurement criteria, and reviewer responsibilities before work begins.